The majority of our cohort were HED patients who were identified to have mutations in EDA (87%), EDARADD (8.7%), and EDAR (4.3%) genes, unlike hidrotic ED patients who represented 17.8% of our cohort and clustered only into EDA mutation spectrum. This evidence concerns the gene EDA and hypohidrotic ectodermal dysplasia.